-
Mashup Score: 0JNCCN 360 - MM - Standardized Assessment of Measurable Residual Disease Via FDG-PET/CT in Myeloma - 7 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cooki es on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Webprogram Unavailable - 7 month(s) ago
Please click HERE if you are not redirected in 5
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Global Treatment Standard in Multiple Myeloma Remains Elusive: Updated Results from the INSIGHT MM Global, Prospective, Observational Study [Dec 10, 2022] @NoemiPuigM et al. @BerdejaJesus Abs 1859 #ASH22 https://t.co/mCCkPgMebV #mmsm #globonc https://t.co/JkTBMSg0au
-
-
Mashup Score: 0JNCCN 360 - Breast - Breast Cancer Screening of Women in Their 40s: Clinical Implications of Canadian Study - 7 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Breast Cancer Screening of Women in Their 40s: Clinical Implications of Canadian Study: https://t.co/FmydfULxJp #bcsm #JNCCN360 #globonc https://t.co/7o1UCusYnR
-
-
Mashup Score: 3JNCCN 360 - Breast - Is Family History Associated With Breast Cancer Prognosis in Sweden? - 7 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Is Family History Associated With #BreastCancer Prognosis in Sweden? https://t.co/2GZwTYxXLw #globonc #JNCCN360 https://t.co/ailbCH8IE4
-
-
Mashup Score: 0JNCCN 360 - Hepatobiliary - Phase IIa Trial Focuses on Second-Line Trifluridine Plus Tipiracil and Irinotecan in Advanced Liver Cancer - 7 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Phase IIa Trial Focuses on Second-Line Trifluridine Plus Tipiracil and Irinotecan in Advanced #LiverCancer: https://t.co/xnrXsFjIMY #hpbcsm #JNCCN360 #globonc https://t.co/h1cFcyGYDE
-
-
Mashup Score: 0JNCCN 360 - Breast - Disparities in Early Breast Cancer Treatment in China Versus the United States - 8 month(s) ago
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Disparities in Early #BreastCancer Treatment in China Versus the United States: https://t.co/TsuAHb3Vov #BCSM #JNCCN360 #globonc https://t.co/wsc7RDGF4p
-
-
Mashup Score: 1Disparities in Cancer Control in Central America and the Caribbean - 8 month(s) ago
Author links open overlay panel Anne Christine Buteau MD a, Alicia Castelo-Loureiro MD b, Regina Barragan-Carrillo MD c, Suyapa Bejarano MD d, Alba J. Kihn-Alarcón MD, MSc e, Enrique Soto-Perez-de-Celis MD, PhD f • Central America and the Caribbean is a highly heterogeneous region with an increasing burden of cancer facing many challenges for providing equitable access to high-quality cancer care. • Barriers for obtaining cancer care across the region include socioeconomic barriers, health-care system
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists2Tweet-
@alicastletree @AnneChr41185205 @ReginaBarCar @ClinicReviews @ElsevierConnect We also provide some key points for guiding policy makers aiming at decreasing cancer control disparities in the region #Latam #Globonc #Globaloncology 👇👇👇👇👇👇👇 https://t.co/JWZNbU41xf https://t.co/13ktm48cp4
-
In the manuscript, we discuss disparities in countries in Central America and the Caribbean, including health system challenges and local initiatives aimed at reducing them #globaloncology #globonc https://t.co/JWZNbU41xf https://t.co/I6PUnS06sc
-
Our manuscript on Cancer Control in Central America and the Caribbean #Latam #Caribbean is online and free to read in @ClinicsReviews Just follow this link 👇👇👇👇👇 https://t.co/JWZNbU41xf @AnneChr41185205 @alicastletree @ReginaBarCar @ajchgt https://t.co/XoXh6TfSab
-
-
Mashup Score: 0JNCCN 360 - Bladder - Does History of Malignancy Impact Oncologic Outcomes in Urothelial Carcinoma? - 10 month(s) ago
By: Vanessa A. Carter, BS Posted: Wednesday, June 21, 2023 According to Jeremy Yuen-Chun Teoh, MBBS, of the Chinese University of Hong Kong and Prince of Wales Hospital, and colleagues, there is little evidence of prognostic factors and individualized surveillance strategies for urothelial carcinoma of the upper…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Does History of Malignancy Impact Oncologic Outcomes in #UrothelialCarcinoma? Read About it on #JNCCN360: https://t.co/QHURDRZkRr #BLCSM #globonc https://t.co/IA3B079Y6H
-
-
Mashup Score: 1JNCCN 360 - Hepatobiliary - Hepatocellular Cancer Survival Rates: Disparity Reported Between Those Born In and Out of the United States - 10 month(s) ago
By: Amanda E. Ruffino, BA Posted: Tuesday, May 30, 2023 Kali Zhou, MD, MAS, of Keck School of Medicine, University of Southern California (USC), Los Angeles, and colleagues examined the association between nativity (birthplace) and survival among adults diagnosed with hepatocellular carcinoma in the United States….
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
HepatocellularCancer Survival Rates: Disparity Between Those Born In & Out of the US: https://t.co/wztxcxeylu #hpbcsm #JNCCN360 #HBC #globonc https://t.co/j199TRDfiX
-
-
Mashup Score: 0JNCCN 360 - Hepatobiliary - Clinical Practice Guidelines for Managing Hepatocellular Carcinoma: An Asian Perspective - 11 month(s) ago
By: Amanda E. Ruffino, BA Posted: Wednesday, May 24, 2023 Joong-Won Park, MD, PhD, of National Cancer Center, Goyang, Korea, and colleagues compared the clinical practice guidelines for the management of hepatocellular carcinoma in Asia, with a focus on China, Hong Kong, Taiwan, Japan, and South Korea. They considered…
Source: jnccn360.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Clinical Practice Guidelines for Managing #HepatocellularCarcinoma: An Asian Perspective: https://t.co/myf0xUOanX #HBC #HPBCSM #globonc #JNCCN360 https://t.co/YQ3QtywBTO
-
Standardized Assessment of Measurable Residual Disease Via FDG-PET/CT in #Myeloma: https://t.co/l0xfYK1e3k #mmsm #JNCCN360 #globonc https://t.co/wkHB045tyS